Have you come across the Clinical Trials Transformation...

Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #

First 91 Last

Share
Profile

Follow
.@#.

665 Posts.

75

04/07/22

07:48

Post #: 62348365
Share

Originally posted by Cosmoclarke: ↑

I guess this isn’t a very popular opinion here, but…. As I’ve said before , the company has struggled to market dx, maybe because of the medical fraternity being difficult to convince, and/or FDA being loathe to ratify the product either because of lack of evidence or lack of support from big pharma.
So we need to keep going with covid testing, as this will bring in revenue, which can then be used to push dx to the world.

It is not going to be easy to convince medical professionals, and we need advertising, advertising and more advertising. We need more exposure, more data, and more staff. We need board members and staff that are qualified to do this, therefore we need to pay more to keep them .
Why does Pfizer want Covid testing? Simple, because it will bring in revenue, fast. So the company needs to move with this opportunity , so that acceptance of dx will follow on the coattails of the acceptance of covid testing, and we can keep on funding the RAP core product…DX.

Flogging the same poor ole horse , the same way , will mean the company will run out of money, and probably add years to the world wide acceptance of DX.

My opinion only.

Expand

Have you come across the Clinical Trials Transformation Initiative, by chance? Apparently Pfizer are a member...

RAP Price at posting: 13.0¢ Sentiment: None Disclosure: Not Held
1 Upvote

0 Great analysis

Reply

Top Stories

Bitcoin: Current State of Play & Where to Next | Swyftx

OSL

Oncosil device successfully treats pancreatic cancer in Türkiye

Earnings Wrap: why is the utilities sector tanking & other big name earnings on Thursday

Emerald & Azure score Digger & Dealer awards

MXR

Maximus picks up 25.93 g/t of gold through infill drilling at WA's Hilditch